{
  "id": 3496970,
  "title": "Akeso, Summit hail ivonescimab's biliary tract cancer win in China-only Phase 3 trial",
  "url": "https://urgent.news/2026/08/26/akeso-summit-hail-ivonescimabs-biliary-tract-cancer-win-in-china-only",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-26T11:02:44.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/akeso-summit-hail-ivonescimabs-biliary-tract-cancer-win-in-china-only-phase-3-trial/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Akeso and its partner Summit Therapeutics proclaimed on Tuesday that their high-profile PD-1xVEGF bispecific hit a major Phase 3 milestone outside of lung cancer. Akeso said ivonescimab met a primary endpoint ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}